Free Trial

Tyra Biosciences (TYRA) SEC Filings & 10K Form

Tyra Biosciences logo
$15.87 -0.34 (-2.10%)
(As of 11/20/2024 ET)

Recent Tyra Biosciences SEC Filings

DateFilerForm TypeView
11/19/2024
8:31 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/14/2024
4:52 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:47 PM
NEXTECH VI ONCOLOGY SCSP (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/14/2024
3:34 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/13/2024
5:04 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
11/08/2024
3:43 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
6:24 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
5:18 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:22 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
4:15 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
6:00 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
7:01 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:15 PM
Boxer Capital Management, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
7:47 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/22/2024
7:49 PM
Boxer Capital Management, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:11 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/22/2024
4:13 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
4:04 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:23 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:12 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
4:51 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
8:59 PM
Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/15/2024
6:22 PM
Boxer Asset Management Inc. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
10/02/2024
4:38 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
5:44 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
5:24 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:49 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:42 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:56 PM
Harris Irrevocable Trust 2 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:59 PM
Harris Irrevocable Trust 3 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:05 PM
Harris Irrevocable Trust 4 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
2:27 PM
Harris Irrevocable Trust 1 U/A DTD 7/24/2017 (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/17/2024
4:12 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:15 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:49 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:53 PM
Tyra Biosciences (Issuer)
Warner Douglas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:50 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:55 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:18 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
6:10 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
06/07/2024
2:08 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
5:26 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Kjellson Nina S (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
MORE ROBERT J (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
KAPLAN GILLA (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Subramony Siddarth (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Tyra Biosciences (Issuer)
Verjee Rehan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:30 PM
Simson Jake (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:46 PM
Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
3:48 PM
Rothenberg Stephen Michael (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:49 PM
Moran Susan (Reporting)
Tyra Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
3:49 PM
Moran Susan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:08 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
11:15 PM
Tyra Biosciences (Filer)
Form EFFECT
04/05/2024
3:20 PM
Tyra Biosciences (Filer)
Form PRE 14A
03/19/2024
6:58 PM
Tada Hiroomi (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
7:01 PM
Fuhrman Alan (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
6:38 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:33 PM
Tyra Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/19/2024
3:35 PM
Tyra Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2024
4:46 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:19 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
03/08/2024
4:38 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
4:40 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:58 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:00 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:24 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
02/09/2024
6:26 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
9:05 AM
FMR LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13G/A
02/08/2024
4:10 PM
Boxer Capital, LLC (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
02/08/2024
4:16 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
4:09 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
7:22 PM
Harris Todd (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
7:23 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
3:56 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2024
3:40 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Tyra Biosciences (Subject)
Form SC 13D/A
02/05/2024
5:05 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
4:04 PM
Bensen Daniel (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:47 PM
Harris Todd (Reporting)
Tyra Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
4:24 PM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
8:00 AM
Tyra Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TYRA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners